To determine whether TUSC2 expression inhibits active PI3K/AKT/mTOR signaling and represses PD-L1, we treated human NSCLC cell lines in which PD-L1 was highly expressed with TUSC2 nanoparticles at multiple time points. The gene discussed is TUSC2; the disease is non-small cell lung carcinoma.